Proto Labs, Inc. $PRLB Shares Sold by Goldman Sachs Group Inc.

Key Points

• Goldman Sachs Group Inc. reduced its stake in Proto Labs by 56.8% during the first quarter, now owning approximately $3.79 million worth of shares.
• Several institutional investors have increased their positions in Proto Labs, with GAMMA Investing LLC leading with a 249.4% increase in holdings in the same period.
• Analyst reports have been positive, with Cantor Fitzgerald and Craig Hallum both raising their price targets, indicating a consensus rating of "Moderate Buy" for the stock.

Goldman Sachs Group Inc. trimmed its holdings in shares of Proto Labs, Inc. (NYSE:PRLB - Free Report) by 56.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 108,211 shares of the industrial products company's stock after selling 142,314 shares during the period. Goldman Sachs Group Inc. owned about 0.46% of Proto Labs worth $3,792,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of PRLB. NewEdge Advisors LLC raised its holdings in Proto Labs by 7,380.0% in the 1st quarter. NewEdge Advisors LLC now owns 748 shares of the industrial products company's stock valued at $26,000 after acquiring an additional 738 shares during the period. GAMMA Investing LLC raised its holdings in Proto Labs by 249.4% in the 1st quarter. GAMMA Investing LLC now owns 926 shares of the industrial products company's stock valued at $32,000 after acquiring an additional 661 shares during the period. CWM LLC increased its holdings in shares of Proto Labs by 50.4% during the first quarter. CWM LLC now owns 1,840 shares of the industrial products company's stock worth $64,000 after purchasing an additional 617 shares during the period. PNC Financial Services Group Inc. increased its holdings in shares of Proto Labs by 14.1% during the first quarter. PNC Financial Services Group Inc. now owns 2,165 shares of the industrial products company's stock worth $76,000 after purchasing an additional 267 shares during the period. Finally, State of Wyoming bought a new position in shares of Proto Labs during the first quarter worth approximately $99,000. 84.54% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Suresh Krishna purchased 1,725 shares of Proto Labs stock in a transaction dated Monday, August 4th. The shares were acquired at an average price of $43.51 per share, for a total transaction of $75,054.75. Following the acquisition, the chief executive officer directly owned 18,021 shares in the company, valued at approximately $784,093.71. The trade was a 10.59% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Insiders own 1.70% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on PRLB shares. Craig Hallum upgraded shares of Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price target on the stock in a research report on Friday, August 1st. Cantor Fitzgerald lifted their target price on shares of Proto Labs from $50.00 to $51.00 and gave the stock an "overweight" rating in a research note on Friday, August 1st. Finally, Wall Street Zen upgraded shares of Proto Labs from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 2nd. Two equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $52.50.

Proto Labs Trading Down 0.8%

Shares of PRLB traded down $0.39 during trading hours on Friday, reaching $50.50. 589,021 shares of the company traded hands, compared to its average volume of 151,804. The firm has a market cap of $1.21 billion, a price-to-earnings ratio of 84.17 and a beta of 1.27. Proto Labs, Inc. has a 12-month low of $26.34 and a 12-month high of $51.20. The stock's fifty day moving average price is $46.12 and its 200 day moving average price is $40.40.

Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $0.41 EPS for the quarter, beating the consensus estimate of $0.33 by $0.08. Proto Labs had a net margin of 2.91% and a return on equity of 2.22%. The business had revenue of $135.06 million during the quarter, compared to analyst estimates of $128.05 million. During the same period in the prior year, the firm posted $0.38 earnings per share. The company's quarterly revenue was up 7.6% on a year-over-year basis. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. On average, research analysts forecast that Proto Labs, Inc. will post 0.81 earnings per share for the current year.

Proto Labs Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.